Core Viewpoint - The stock of Kefu Medical (301087) has shown a slight increase in price, with significant fluctuations in capital flow, indicating mixed investor sentiment and potential growth opportunities in the medical device sector [1][2]. Group 1: Stock Performance - As of November 24, 2025, Kefu Medical's stock closed at 41.36 yuan, up by 1.17%, with a turnover rate of 0.72% and a trading volume of 14,000 hands, resulting in a transaction amount of 57.93 million yuan [1]. - The net capital outflow from major investors was 567.49 million yuan, accounting for 9.8% of the total transaction amount, while retail investors saw a net inflow of 354.14 million yuan, representing 6.11% of the total [1]. Group 2: Financial Metrics and Industry Comparison - Kefu Medical's total market value is 8.64 billion yuan, which is below the industry average of 10.978 billion yuan, ranking 43 out of 124 in the medical device sector [2]. - The company reported a net profit of 260 million yuan for the first three quarters of 2025, reflecting a year-on-year increase of 3.3%, with a gross margin of 53.35%, which is higher than the industry average of 51.22% [2]. - The company's price-to-earnings ratio (P/E) stands at 24.9, significantly lower than the industry average of 55.96, indicating a potentially undervalued stock [2]. Group 3: Institutional Ratings - In the last 90 days, eight institutions have rated Kefu Medical with a "buy" recommendation, and the average target price set by these institutions is 53.84 yuan [3].
股票行情快报：可孚医疗（301087）11月24日主力资金净卖出567.49万元